P2.11-10 Discovery of Potential Biomarkers That Discriminate Early Stage NSCLC from Controls by Non-Targeted Metabolomics Profiling

Autor: Kim, J., Balshaw, R., Trevena, C., Banerji, S., Murphy, L., Dawe, D., Tan, L., Srinathan, S., Buduhan, G., Kidane, B., Qing, G., Domaratzki, M., Aliani, M.
Zdroj: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S795-S796
Databáze: ScienceDirect